By
Penn State
Published: Jan. 6, 2021, 8:33 p.m.·
Tags:
Scientific research
UNIVERSITY PARK, Pa. — Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust. In an effort to reduce the potential infection-caused 10 million deaths worldwide, Penn State researcher Scott Medina has developed a peptide, or small protein, that can target a specific pathogen without damaging the good bacteria that bolsters the immune system.
Read More →
By
Penn State
Published: June 15, 2020, 3:17 p.m.·
Tags:
TB epidemiology,
Public health
UNIVERSITY PARK, Pa. — The number of human tuberculosis (TB) cases that are due to transmission from animals, as opposed to human-to-human transmission, may be much higher than previously estimated, according to an international team of researchers. The results could have implications for epidemiological studies and public health interventions.
Read More →
By
Penn State
Published: Sept. 24, 2018, 10:15 a.m.·
Tags:
Medicines,
Scientific research
A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity. A paper describing the research appears September 20, 2018 in the journal Molecular Cell.
Read More →